CN102451330A - Traditional Chinese medicine for treating sterility due to blood stasis - Google Patents

Traditional Chinese medicine for treating sterility due to blood stasis Download PDF

Info

Publication number
CN102451330A
CN102451330A CN2010105239608A CN201010523960A CN102451330A CN 102451330 A CN102451330 A CN 102451330A CN 2010105239608 A CN2010105239608 A CN 2010105239608A CN 201010523960 A CN201010523960 A CN 201010523960A CN 102451330 A CN102451330 A CN 102451330A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
blood
blood stasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105239608A
Other languages
Chinese (zh)
Inventor
吴肖慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105239608A priority Critical patent/CN102451330A/en
Publication of CN102451330A publication Critical patent/CN102451330A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating sterility due to blood stasis. The traditional Chinese medicine is characterized by being prepared from the following raw materials in parts by weight: 1-3 parts of peach kernel, 6-9 parts of safflower, 4-8 parts of tree peony bark, 6-9 parts of red paeonia, 2-6 parts of angelica, 2-6 parts of corydalis tuber, 2-6 parts of bitter orange, 2-6 parts of laminaria and 2-6 parts of rhizoma cyperi. The traditional Chinese medicine for treating sterility due to blood stasis has the efficacies of soothing liver and regulating qi flow, tonifying blood and promoting blood circulation, regulating menstruation and relieving pain. The active ingredients of the traditional Chinese medicine for treating sterility due to blood stasis disclosed by the invention are easy to dissolve in water, thus the traditional Chinese medicine is easy to absorb by a human body, and has low cost, obvious effect and no any side effect.

Description

The Chinese medicine of treatment hemostagnant sterility
Technical field
The present invention relates to treat the field of Chinese medicines of hemostagnant sterility.
Background technology
Sterility and infertility is a common clinical, and its sickness rate accounts for women's at reproduction age 10%.The factor that causes sterility and infertility is more.For example: heat in blood, suffer from a deficiency of the kidney, blood stasis, insufficiency of the spleen, stagnation of liver-QI etc., all can cause infertile.In the prior art, to the sterility and infertility that the various causes of disease cause, many corresponding Chinese medicine preparation are arranged all, it is undesirable to exist effect, and cost is higher, takes technological deficiencies such as inconvenience.
Summary of the invention
The object of the present invention is to provide a kind ofly have depressed liver-energy dispersing and QI regulating, enrich blood invigorate blood circulation, the Chinese medicine preparation of menstruction regulating and pain relieving effect, have excellent curative to hemostagnant sterility.
The present invention finds in following ranges, all to have good prevention effect through repetition test, and raw materials of traditional Chinese medicinal materials and the composition by weight thereof chosen are respectively:
Semen Persicae 1-3 part, Flos Carthami 6-9 part, Cortex Moutan 4-8 part, Radix Paeoniae Rubra 6-9 part, Radix Angelicae Sinensis 2-6 part, Rhizoma Corydalis 2-6 part, Fructus Aurantii 2-6 part, Thallus Laminariae (Thallus Eckloniae) 2-6 part, Rhizoma Cyperi 2-6 part;
Preferably: 3 parts in Semen Persicae, 6 parts on Flos Carthami, 4 parts of Cortex Moutans, 6 parts of Radix Paeoniae Rubra, 2 parts of Radix Angelicae Sinensis, 4 parts of Rhizoma Corydalis, 6 parts of Fructus Aurantiis, 4 parts of Thallus Laminariae (Thallus Eckloniae)s, 5 parts of Rhizoma Cyperis
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations.For example can these crude drug pulverize mix homogeneously powder be taken after mixing it with water; Can be with these crude drug decocting together, concentrate decocting liquid then and take, perhaps be condensed into cream to concentrated decocting liquid and be processed into pill and take; Bring into play drug effect better for each raw material that makes this medicine, carry out special extraction to certain crude drug, like ethanol extraction, these can not be used to limit protection scope of the present invention.Active component of the present invention can add various conventional adjuvant required when preparing different dosage form; Be prepared into any peroral dosage form commonly used like disintegrating agent, lubricant, binding agent etc. with the method for Chinese medicinal of routine, like pill, powder, tablet, capsule, oral liquid etc.
In the raw materials of traditional Chinese medicinal materials that the present invention chooses, its effect and pharmacological action are respectively:
Semen Persicae: [effect] promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing.[curing mainly] excited uterus, anticoagulation, antithrombotic, antiinflammatory, antiallergic, analgesia, effects such as antitussive and intestine moistening cathartic.
Flos Carthami: the excited uterus of [effect] [curing mainly], blood vessel dilating, microcirculation improvement reduces coronary resistance, coronary blood flow increasing, resisting myocardial ischemia, anticoagulation, antithrombotic forms, effects such as blood fat reducing and antiinflammatory.
Cortex Moutan: [effect] clearing away heat and cooling blood, promoting blood circulation to remove blood stasis.[curing mainly] let out row clearly and loose, and reducing the asthenic fever passes through the cloudy latent heat that divides, amenorrhea due to stagnation of blood, and dysmenorrhea, postpartum stagnation, the leprosy abdominal mass, traumatic injury is hindered swollen.
Radix Paeoniae Rubra: [effect] clearing away heat and cooling blood, stasis-dispelling and pain-killing.[curing mainly] cooling blood and removing stasis, it is hot and suffocating that clearing away liver-fire removes blood system, and reducing the asthenic fever passes through the cloudy latent heat that divides, amenorrhea due to stagnation of blood, dysmenorrhea, postpartum stagnation, the leprosy abdominal mass, traumatic injury is hindered swollen.
Radix Angelicae Sinensis: [effect] enriched blood and invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.[curing mainly] anti-anemia promotes immunologic function, anticoagulant, and antithrombotic, the resisting myocardial ischemia anoxia, the expansion peripheral blood vessel, blood pressure lowering, excited or suppress uterine smooth muscle, lax tracheal smooth muscle, blood fat reducing, antiinflammatory and effect such as protect the liver.
Rhizoma Corydalis: [effect] invigorates blood circulation, circulation of qi promoting, pain relieving.[curing mainly] analgesia, calmness, hypnosis, convulsion, coronary artery dilator, coronary blood flow increasing, resisting myocardial ischemia, anticoagulant, antithrombotic, effects such as arrhythmia and antiulcer.
Fructus Aurantii: [effect] regulating the flow of QI to ease the stomach, the stagnant relieving distension of row.[curing mainly] stagnation of QI in spleen and stomach, distension and fullness in the abdomen, the stagnation of QI is uncomfortable in chest.
Thallus Laminariae (Thallus Eckloniae): [effect] eliminating phlegm and softening indurated mass, diuretic.
Rhizoma Cyperi: [effect] depressed liver-energy dispersing and QI regulating, menstruction regulating and pain relieving.[curing mainly] suppressed the uterus, and gastrointestinal and tracheal smooth muscle, and the promotion bile secretion is arranged are analgesic, analgesia, antiinflammatory, blood pressure lowering, heart tonifying, antibacterial and estrogen-like effects etc.
Product efficacy: the Chinese medicine of treatment hemostagnant sterility of the present invention has depressed liver-energy dispersing and QI regulating, enrich blood invigorate blood circulation, the effect of menstruction regulating and pain relieving;
Clinical application effect: utilize the Chinese medicine of treatment hemostagnant sterility according to the invention,, carry out clinical treatment to being diagnosed as hemostagnant sterility patient's 67 of women at reproduction age; 27.6 years old mean age, use treatment by Chinese herbs 1-3 course of treatment of treatment sterility due to deficiency of the kidney of the present invention, 14 days each courses of treatment, effective 48 examples; Evaluation criterion is an impregnation.Find that through clinical practice the Chinese medicine of treatment hemostagnant sterility of the present invention during its active ingredient is soluble in water, is beneficial to absorption by human body, with low cost, effect is obvious, and is without any side effects, without any side effects.
The practical implementation method
The Chinese medicine of treatment hemostagnant sterility of the present invention is characterized in that being processed by following raw material, and its composition by weight is respectively:
Semen Persicae 1-3 part, Flos Carthami 6-9 part, Cortex Moutan 4-8 part, Radix Paeoniae Rubra 6-9 part, Radix Angelicae Sinensis 2-6 part, Rhizoma Corydalis 2-6 part, Fructus Aurantii 2-6 part, Thallus Laminariae (Thallus Eckloniae) 2-6 part, Rhizoma Cyperi 2-6 part;
Preferably: 3 parts in Semen Persicae, 6 parts on Flos Carthami, 4 parts of Cortex Moutans, 6 parts of Radix Paeoniae Rubra, 2 parts of Radix Angelicae Sinensis, 4 parts of Rhizoma Corydalis, 6 parts of Fructus Aurantiis, 4 parts of Thallus Laminariae (Thallus Eckloniae)s, 5 parts of Rhizoma Cyperis.

Claims (1)

1. Chinese medicine of treating hemostagnant sterility; It is characterized in that being processed by following raw material, its composition by weight is respectively: Semen Persicae 1-3 part, Flos Carthami 6-9 part, Cortex Moutan 4-8 part, Radix Paeoniae Rubra 6-9 part, Radix Angelicae Sinensis 2-6 part, Rhizoma Corydalis 2-6 part, Fructus Aurantii 2-6 part, Thallus Laminariae (Thallus Eckloniae) 2-6 part, Rhizoma Cyperi 2-6 part;
Preferably: 3 parts in Semen Persicae, 6 parts on Flos Carthami, 4 parts of Cortex Moutans, 6 parts of Radix Paeoniae Rubra, 2 parts of Radix Angelicae Sinensis, 4 parts of Rhizoma Corydalis, 6 parts of Fructus Aurantiis, 4 parts of Thallus Laminariae (Thallus Eckloniae)s, 5 parts of Rhizoma Cyperis.
CN2010105239608A 2010-10-29 2010-10-29 Traditional Chinese medicine for treating sterility due to blood stasis Pending CN102451330A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105239608A CN102451330A (en) 2010-10-29 2010-10-29 Traditional Chinese medicine for treating sterility due to blood stasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105239608A CN102451330A (en) 2010-10-29 2010-10-29 Traditional Chinese medicine for treating sterility due to blood stasis

Publications (1)

Publication Number Publication Date
CN102451330A true CN102451330A (en) 2012-05-16

Family

ID=46035273

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105239608A Pending CN102451330A (en) 2010-10-29 2010-10-29 Traditional Chinese medicine for treating sterility due to blood stasis

Country Status (1)

Country Link
CN (1) CN102451330A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189814A (en) * 2014-08-21 2014-12-10 任有德 Traditional Chinese medicine composition for treating infertility and preparation method thereof
CN113440569A (en) * 2021-07-01 2021-09-28 北京溢康源医药科技有限公司 Jiuwei Xiao soft capsule formula and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189814A (en) * 2014-08-21 2014-12-10 任有德 Traditional Chinese medicine composition for treating infertility and preparation method thereof
CN113440569A (en) * 2021-07-01 2021-09-28 北京溢康源医药科技有限公司 Jiuwei Xiao soft capsule formula and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103169928B (en) Externally applied traditional Chinese medicine composition for treating dysmenorrhea, as well as preparation method and application thereof
CN103520572B (en) A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof
CN103751570A (en) Orally taken traditional Chinese medicine for treating migraine
CN102366508A (en) Traditional Chinese medicine preparation for treating obstructive infertility of fallopian tube
CN105749179A (en) Traditional Chinese medicine composition for treating metabolic syndrome
CN105362650A (en) Pharmaceutical composition for treating constipation and application method thereof
CN104984316A (en) Medicine for treating female cold in uterus
CN102836409A (en) Traditional Chinese medicine for treating postpartum lochiorrhea and preparation method
CN102120020A (en) Medicinal composition for treating hyperplastic diseases of breast and hysteromyoma and preparation method thereof
CN103432559A (en) Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof
CN102847074B (en) Blood stasis removing pill for treating ankylosing spondylitis
CN102579610B (en) Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof
CN104225486A (en) Traditional Chinese medicine for treating chronic cholecystitis
CN102451331A (en) Traditional Chinese preparation for treating barrenness
CN101601850B (en) Lactagogue and health care traditional Chinese medicine for lying-in women
CN104587206A (en) Medicament for treating bedsore and preparation method of medicament
CN102451330A (en) Traditional Chinese medicine for treating sterility due to blood stasis
CN103877556A (en) Traditional Chinese medicine plaster for bone injury and fracture
CN102145099A (en) Traditional Chinese medicine for treating infertility caused by liver stagnation
CN103656525A (en) Traditional Chinese medicinal composition for treating dysmenorrhea
CN105796713A (en) Rose traditional Chinese medicine composition capable of relieving pain and preparation method and application thereof
CN104815276A (en) Oral medicine for treating recurrent spontaneous abortion and preparation method thereof
CN104189615B (en) Traditional Chinese medicine preparation for treating metrorrhagia and metrostaxis, and preparation method of traditional Chinese medicine preparation
CN102058681A (en) Traditional Chinese medicine for treating protrusion of lumbar vertebral disc and waist and leg pain and preparation method thereof
CN109833371B (en) Traditional Chinese medicine composition for treating constipation after hemorrhoids and fistula operation and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120516